alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 77, Number 50 (Wednesday, March 14, 2012)]
[Proposed Rules]
[Page 15019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6104]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service

50 CFR Parts 13, 17, and 23

[Docket No. FWS-R9-IA-2010-0083; 96300-1671-0000-R4]
RIN 1018-AW82


Revision of Regulations Implementing the Convention on 
International Trade in Endangered Species of Wild Fauna and Flora 
(CITES); Updates Following the Fifteenth Meeting of the Conference of 
the Parties to CITES; Correction

AGENCY: Fish and Wildlife Service, Interior.

ACTION: Proposed rule; correction.

-----------------------------------------------------------------------

SUMMARY: On March 8, 2012, we, the Fish and Wildlife Service (FWS or 
Service), published a proposed rule to revise the regulations that 
implement the Convention on International Trade in Endangered Species 
of Wild Fauna and Flora (CITES) by incorporating certain provisions 
adopted at the fourteenth and fifteenth meetings of the Conference of 
the Parties (CoP14 and CoP15) to CITES and clarifying and updating 
certain other provisions. Inadvertently, we made some errors in the 
DATES and ADDRESSES sections concerning the information collection 
aspects of the proposal. With this technical correction, we correct 
those errors.

FOR FURTHER INFORMATION CONTACT: Robert R. Gabel, Chief, Division of 
Management Authority; U.S. Fish and Wildlife Service; 4401 N. Fairfax 
Drive, Suite 212; Arlington, VA 22203; telephone, 703-358-2093.

SUPPLEMENTARY INFORMATION: On March 8, 2012 (77 FR 14200), we published 
a proposed rule to revise the regulations that implement CITES. 
Inadvertently, we made some errors in the DATES and ADDRESSES sections 
concerning the information collection aspects of the proposal. With 
this technical correction, we correct those errors.
    Under DATES, we printed an incorrect date for the deadline for 
comments on the information collection aspects of the proposed rule. 
The correct date is April 9, 2012. Comments on the information 
collection aspects of this proposed rule will be considered if received 
by April 9, 2012.
    Under ADDRESSES, we printed an incorrect address to which to 
provide us a copy of your comments on the information collection 
aspects of the proposed rule. Please provide those comments to the 
Service Information Collection Clearance Officer, U.S. Fish and 
Wildlife Service, MS 2042-PDM, 4401 N. Fairfax Drive, Arlington, VA 
22203.

    Dated: March 8, 2012.
Sara Prigan,
Federal Register Liaison.
[FR Doc. 2012-6104 Filed 3-13-12; 8:45 am]
BILLING CODE 4310-55-P
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D18-1449

_____________________________

DYLAN EDWARD SIZEMORE,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

_____________________________

On appeal from the Circuit Court for Santa Rosa County.

John F. Simon, Judge.

May 21, 2019

PER CURIAM.

AFFIRMED.

WETHERELL, RAY, and WINSOR, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
2

Andy Thomas, Public Defender, and Steven L. Seliger, Assistant 

Public Defender, Tallahassee, for Appellant.

Ashley Moody, Attorney General, Tallahassee, for Appellee.
**Exhibit 8.1**

 

**Subsidiaries of DRAXIS Health Inc.**

 

| **Subsidiary**                               | ** ** | **Jurisdiction of Incorporation**                                   | ** ** | **Other names which Subsidiaryis doing business**                                            |
|----------------------------------------------|------------|---------------------------------------------------------------------|------------|----------------------------------------------------------------------------------------------|
| ** **                                   | ** ** | ** **                                                          | ** ** | ** **                                                                                   |
| DRAXIS Specialty Pharmaceuticals Inc.        |       | Canada (CBCA)                                                       |       | ·  DRAXIS Pharma, a division of DRAXIS Specialty Pharmaceuticals Inc.

  |
|                                         |       |                                                                |       | ·  DRAXIMAGE, a division of DRAXIS Specialty Pharmaceuticals Inc.

      |
| Deprenyl Animal Health, Inc.            |       | State of Louisiana                                                  |       | DAHI                                                                                         |
| DAHI LLC                                     |       | State of Delaware                                                   |       |                                                                                         |
| DAHI Nevada Inc.                             |       | State of Nevada                                                     |       |                                                                                         |
| DRAXIS U.S. Inc.                             |       | State of Delaware                                                   |       |                                                                                         |
| DAHI Animal Health (New Zealand) Pty Limited |       | New Zealand (Companies Act 1993 as a limited liability company)     |       |                                                                                         |
| DAHI Animal Health (UK) Limited              |       | England and Wales (Companies Act 1985 as a private limited company) |       |                                                                                         |
| DRAXIMAGE LLC                                |       | State of Delaware                                                   |       |                                                                                         |
| DRAXIMAGE (U.K.) Limited                     |       | England and Wales (Companies Act 1985 as a private limited company) |       |                                                                                         |
| 4271513 Canada Inc.                          |       | Canada (CBCA)                                                       |       |                                                                                         |
EXHIBIT 32.2








CERTIFICATION OF CHIEF FINANCIAL OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of BigString Corporation (the “Company”) on Form 10-Q for the period ended June 30, 2009 (the “Report”), I, Robert S. DeMeulemeester, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. §1350,
as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:




(1)
the Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934, 15 U.S.C. §78m or 78o(d), and,




(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Dated:  August 14, 2009
/s/ Robert S. DeMeulemeesterRobert S. DeMeulemeesterChief Financial Officer
#### Thomas N. RYON, M.D., Thomas N. Ryon, M.D., P.A., Petitioners, v. Honorable James M. REASBECK, Circuit Court Judge of the Seventeenth Judicial Circuit in and for Broward County, Respondent; The FLORIDA PATIENT’S COMPENSATION FUND, Petitioner, v. Honorable James M. REASBECK, Circuit Court Judge of the Seventeenth Judicial Circuit in and for Broward County, Respondent.

Nos. 88-1011, 88-1106.

District Court of Appeal of Florida, Fourth District.

June 2, 1988.

Debra J. Snow and Robert M. Klein of Stephens, Lynn, Klein & McNicholas, P.A., Miami, for petitioners-Ryon.

Theodore R. Dempster of Law Offices of Bruce S. Schwartz, P.A., North Miami Beach, for petitioner-The Florida Patient’s Compensation Fund.

Jane Kreusler-Walsh and Larry Klein of Klein & Beranek, P.A., West Palm Beach, Sheldon J. Schlesinger, P.A., Fort Lauder-dale, for respondent.

James M. Reasbeck, pro se.

PER CURIAM.

Petitioners seek a writ of prohibition to prohibit respondent from presiding in further proceedings in the case of Freída McDermott, as personal representative of the Estate of Joseph McDermott, deceased, plaintiff, vs. Thomas N. Ryon, M.D., Thomas N. Ryon, M.D., P.A., d/b/a Ryon Medi*1025cal Center, and The Florida Patient’s Compensation Fund, Case No. 87-10322 CP in the Circuit Court of the Seventeenth Judicial Circuit, in and for Broward County, Florida. Initially we note that the facts as alleged in petitioners’ verified motion for recusal and disqualification did not present legally sufficient ground for disqualification of respondent. However, respondent’s comments during the hearing on petitioners’ motion and the argument made by respondent in responding to an order to show cause issued by this court, shows that respondent went beyond a determination of the sufficiency of the motion to disqualify. Therefore we grant petitioners’ petition for writ of prohibition on the authority of *Bundy v. Rudd,*366 So.2d 440 (Fla.1978); *Gieseke v. Moriarty,*471 So.2d 80 (Fla. 4th DCA 1985) and *Fruehe v. Reasbeck,*525 So.2d 471 (Fla. 4th DCA 1988).

PROHIBITION GRANTED.

DOWNEY, DELL and GUNTHER, JJ., concur.
**Certification      Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

|  | 1. | The                Report complies in all material respects with the requirements of                section                13(a) or 15(d) of the Securities Exchange Act of 1934, as amended,                and |
|--|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 2. | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of                Registrant. |
|--|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |                                                                                                                                                        |                                         |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------|
|   |                                                                                                                                                        |                                         |
|        |                                                                                                                                                             | /s/ John                S. Kovach  |
|   | John                S. KovachChief                Executive Officer and Chief Financial Officer (principal                financial and accounting officer) |

----
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<RESTATED> 
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                      18,775,240
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                345,069,507
<INVESTMENTS-CARRYING>                     942,816,546
<INVESTMENTS-MARKET>                       948,645,106
<LOANS>                                     54,391,985
<ALLOWANCE>                                  (100,000)
<TOTAL-ASSETS>                           1,465,507,541
<DEPOSITS>                                 905,304,565
<SHORT-TERM>                               434,168,072
<LIABILITIES-OTHER>                         13,562,592
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                       24,189,409
<PREFERRED>                                          0
<COMMON>                                        67,261
<OTHER-SE>                                  88,215,642
<TOTAL-LIABILITIES-AND-EQUITY>           1,465,507,541
<INTEREST-LOAN>                              3,002,800
<INTEREST-INVEST>                           82,729,082
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                            85,731,882
<INTEREST-DEPOSIT>                          29,403,308
<INTEREST-EXPENSE>                          59,038,125
<INTEREST-INCOME-NET>                       26,693,757
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                             832,491
<EXPENSE-OTHER>                             99,584,114
<INCOME-PRETAX>                             25,965,692
<INCOME-PRE-EXTRAORDINARY>                  25,965,692
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                15,054,843
<EPS-PRIMARY>                                     2.25
<EPS-DILUTED>                                     2.18
<YIELD-ACTUAL>                                    1.85
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               100,000
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                              100,000
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                        100,000
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 17-7149

IAN AULDEN CAMPBELL,

 Plaintiff - Appellant,

v.

DONALD W. STEPHENS,

 Defendant - Appellee.

Appeal from the United States District Court for the Eastern District of North Carolina, at 

Raleigh. Terrence W. Boyle, District Judge. (5:16-ct-03321-BO)

Submitted: November 21, 2017 Decided: November 28, 2017

Before WYNN and THACKER, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by unpublished per curiam opinion.

Bruce Tracy Cunningham, Jr., LAW OFFICE OF BRUCE T. CUNNINGHAM, JR., 

Southern Pines, North Carolina, for Appellant.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Ian Aulden Campbell appeals the district court’s order dismissing his 42 U.S.C. 

§ 1983 (2012) complaint in which he alleged that the state court judge who denied his 

post-conviction motion for appropriate relief violated his rights to due process because 

the judge lacked the appearance of impartiality. Campbell’s claims are without merit. 

See Tumey v. Ohio, 273 U.S. 510, 523 (1927) (discussing lack of appearance of 

impartiality of deciding judge as violation of defendant’s rights to due process). 

Accordingly, we affirm the district court’s order. We dispense with oral argument 

because the facts and legal contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          26,186
<SECURITIES>                                    12,188
<RECEIVABLES>                                   13,528
<ALLOWANCES>                                     2,317
<INVENTORY>                                          0
<CURRENT-ASSETS>                                53,320
<PP&E>                                           8,255
<DEPRECIATION>                                   3,950
<TOTAL-ASSETS>                                  59,450
<CURRENT-LIABILITIES>                           16,152
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           126
<OTHER-SE>                                      43,172
<TOTAL-LIABILITY-AND-EQUITY>                    59,450
<SALES>                                         37,161
<TOTAL-REVENUES>                                50,514
<CGS>                                            2,843
<TOTAL-COSTS>                                    6,333
<OTHER-EXPENSES>                                38,164
<LOSS-PROVISION>                                   677
<INTEREST-EXPENSE>                                  23
<INCOME-PRETAX>                                  7,363
<INCOME-TAX>                                     2,757
<INCOME-CONTINUING>                              4,606
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                        0
<NET-INCOME>                                     4,606
<EPS-PRIMARY>                                     0.38
<EPS-DILUTED>                                     0.36


</TABLE>
[Federal Register Volume 77, Number 54 (Tuesday, March 20, 2012)]
[Notices]
[Page 16221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6647]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission


Notice of Commission Staff Attendance

    The Federal Energy Regulatory Commission hereby gives notice that 
members of the Commission's staff may attend the following meeting 
related to the transmission planning activities of the PJM 
Interconnection, L.L.C. (PJM):

PJM Regional Transmission Planning Task Force Subgroup

    March 16, 2012, 9 a.m.-12 p.m., Local Time.
    The above-referenced meeting will be held over conference call 
only.
    The above-referenced meeting is open to stakeholders.
    Further information may be found at www.pjm.com.
    The discussions at the meetings described above may address matters 
at issue in the following proceedings:
    Docket No. EL05-121, PJM Interconnection, L.L.C.
    Docket No. ER06-456, ER06-954, ER06-1271, ER07-424, ER06-880, EL07-
57, ER07-1186, ER08-229, ER08-1065, ER09-497, and ER10-268, PJM 
Interconnection, L.L.C.
    Docket No. ER10-253 and EL10-14, Primary Power, L.L.C.
    Docket No. EL10-52, Central Transmission, LLC v. PJM 
Interconnection, L.L.C.
    Docket No. ER11-4070, RITELine Indiana et al.
    Docket No. ER11-2875 and EL11-20, PJM Interconnection, L.L.C.
    Docket No. ER09-1256, Potomac-Appalachian Transmission Highline, 
L.L.C.
    Docket No. ER09-1589, FirstEnergy Service Company
    Docket No. EL11-56, FirstEnergy Service Company
    Docket No. ER11-1844, Midwest Independent Transmission System 
Operator, Inc.
    Docket No. EL12-10, PJM Interconnection, L.L.C.
    Docket No. ER12-718, New York Independent System Operator, Inc.
    Docket No. EL12-1177, PJM Interconnection, L.L.C.
    Docket No. EL12-1178, PJM Interconnection, L.L.C.
    For more information, contact Jonathan Fernandez, Office of Energy 
Market Regulation, Federal Energy Regulatory Commission at (202) 502-
6604 or <a href="/cdn-cgi/l/email-protection#513b3e3f302539303f7f3734233f303f35342b11373423327f363e27"><span class="__cf_email__" data-cfemail="b1dbdedfd0c5d9d0df9fd7d4c3dfd0dfd5d4cbf1d7d4c3d29fd6dec7">[email protected]</span></a>.

    Dated: March 14, 2012.
Kimberly D. Bose,
Secretary.
[FR Doc. 2012-6647 Filed 3-19-12; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>

                                                                    Exhibit 31.1

CERTIFICATION

I, Monroe J. Carell, Jr., certify that:

      1.    I have reviewed this annual report on Form 10-K of Central Parking
Corporation;

      2.    Based on my knowledge, this annual report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
annual report;

      3.    Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

      4.    The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      a)    designed such disclosure controls and procedures or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this annual report is being prepared;

      b)    evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

      c)    disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

      5.    The registrant's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of registrant's
board of directors (or persons performing the equivalent function):

      a)    all significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

      b)    any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.

Date: December 14, 2004                  By: /s/ MONROE J. CARELL, JR.
                                           ------------------------------------
                                           Monroe J. Carell, Jr.
                                           Chairman and Chief Executive Officer
#### STATE of Louisiana v. Joseph NIXON (three cases).

No. 89-K-0595.

Supreme Court of Louisiana.

June 30, 1989.

In re State of Louisiana; — Plaintiff(s); applying for writ of certiorari and/or review; to the Court of Appeal, First Circuit, Nos. KA88 0917, KA88 0918, KA88 0919; Parish of East Baton Rouge, 19th Judicial District Court, Div. “D”, Nos. 8-86-271, 8-86-270, 7-86-51.

*1211Prior report: La.App., 537 So.2d 326.

Denied.

DIXON, C.J., would grant and reverse the Court of Appeal and remand.